1,395
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Anti-HIV-1 integrase activity of Mimusops elengi leaf extracts

, &
Pages 58-61 | Received 27 Sep 2012, Accepted 24 May 2013, Published online: 13 Sep 2013
 

Abstract

Context: Integrase (IN) is one of the three human immunodeficiency virus type 1 (HIV-1) enzymes that, together with a reverse transcriptase and protease, allow the virus to reproduce itself after infecting the host cells. Any new knowledge on inhibitors of this enzyme could provide essential clues for the development of anti-HIV drugs.

Objective: To evaluate the anti-HIV-1 IN activity of some Thai medicinal plant extracts, and to isolate the active compounds from the extract that possessed the strongest anti-HIV-1 IN activity.

Materials and methods: Ethanol extracts of eight Thai medicinal plants (10–100 µg/mL) were evaluated for their inhibitory effect against HIV-1 IN. An extract of Mimusops elengi L. (Sapotaceae) leaves that possessed the strongest anti-HIV-1 IN activity was fractionated to isolate the active compounds by an anti-HIV-1 IN assay-guided isolation process.

Results and discussion: The leaf extract from M. elengi had the strongest anti-HIV-1 IN activity with an IC50 value of 62.1 µg/mL. A bioassay-guided isolation of the active compounds from M. elengi leaf extract resulted in the isolation of active compounds, identified as a mixture of gallocatechin and epigallocatechin. This mixture of gallocatechin and epigallocatechin showed satisfactory anti-HIV-1 IN activity with an IC50 value of 35.0 µM. A flavanol glycoside, mearnsitrin was also isolated but was inactive at a concentration of 100 µM.

Acknowledgements

The authors thank the Prince of Songkla University for support in the form of a research grant, and Dr. Robert Craigie, the National Institute of Health, Bethesda, Maryland, USA, for providing HIV-1 integrase enzyme. Also thanks to Dr. Brian Hodgson for assistance with the English.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.